In several malignancies, including pancreatic cancer, XDH, a rate-limiting enzyme that catalyzes the last stage of purine metabolism, was a reliable predictor for poor prognosis in many cancers including pancreatic cancer. This evidence concerns the gene XDH and familial pancreatic carcinoma.